ATLANTA and ROCKVILLE, Md., August 12, 2002 – NDCHealth Corporation (NYSE: NDC) today announced a strategic agreement with DrFirst.com Inc. that allows users of DrFirst’s Rcopia prescription management system to transmit prescription messages electronically to pharmacies nationwide using the private and secure NDCHealth Information Network.
“We are pleased to partner with DrFirst to extend our electronic prescribing solutions,” said Walter M. Hoff, chief executive officer of NDCHealth. “Our partnership with DrFirst enhances our efforts to make electronic prescribing a seamless part of physicians’ and pharmacists’ normal business workflow. NDCHealth is committed to furthering physicians’ electronic prescribing capabilities across the U.S.”
Rcopia provides integrated Web- and PDA-based electronic prescribing abilities from desktop computers and handheld devices. The NDCHealth Information Network capabilities provide pharmacy access allowing prescriptions to be transmitted electronically into the pharmacy’s information system directly.
DrFirst.com provides a suite of products and services to the healthcare community including: fully integrated Web and PDA-based electronic prescription writing designed to be used anywhere, any time, on any device; a practice management solution that includes automated billing, electronic claims submission and scheduling; a state-of-the-art electronic medical records application; and a complementary suite of integrated products that includes charge capture and secure e-mail. DrFirst is located in Rockville, Maryland, and has 10 major hospital clients including MedStar Health, the largest health system in the Baltimore-Washington, DC region. DrFirst also provides the industries best secure messaging platform for physicians, hospitals and EMR/EHR vendors.
NDCHealth is a leading provider of health information services to pharmacy, hospital, physician, pharmaceutical and payer businesses.
This press release may contain forward-looking statements concerning the Company’s future operations, performance and financial condition. These statements are subject to a number of risks and uncertainties, such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, development difficulties, the ability to consummate and integrate acquisitions, and other risks detailed in the Company’s SEC filings including the most recent form 10-K. The Company undertakes no obligation to revise any of these statements to reflect future circumstances or the occurrence of unanticipated events.
Atlanta, GA 30329-2010
Contact: Betty Feezor